Skip to main content
CSL Limited (CSLLY)
OTCMKTS · Delayed Price · Currency is USD
25.15
-0.26 (-1.02%)
At close: Mar 6, 2026

CSL Limited Revenue

CSL Limited had revenue of $8.33B in the half year ending December 31, 2025, with 3.46% growth. This brings the company's revenue in the last twelve months to $15.41B, up 1.16% year-over-year. In the fiscal year ending June 30, 2025, CSL Limited had annual revenue of $15.56B with 5.12% growth.

Revenue (ttm)
15.41B
Revenue Growth
+1.16%
P/S Ratio
3.20
Revenue / Employee
515.22K
Employees
29,904
Market Cap
49.37B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 202515.56B758.00M5.12%
Jun 30, 202414.80B1.49B11.19%
Jun 30, 202313.31B2.75B26.02%
Jun 30, 202210.56B252.00M2.44%
Jun 30, 202110.31B1.16B12.67%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Northwest Biotherapeutics 937.00K
Silence Therapeutics 25.83M
Vaxart 148.20M
BioStem Technologies 292.21M
Nuo Therapeutics 2.61M
Arch Biopartners 115.29K
ZIVO Bioscience 209.03K
Revenue Rankings

CSL Limited News

More News